MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Meetings / education regarding pharmacy issues. Prescription drug supply chain issues, including security of the supply chain and other related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Taxation/Internal Revenue Code TAX
Meetings / education regarding the implementation of new medical device tax. Meetings / education regarding proposals to repeal LIFO.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Veterans VET
Education regarding the existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Health Issues HCR
Meetings/education regarding incentives for health information technology, Affordable Care Act implementation and other healthcare policy issues. Proposed regulation of medical software. Various issues in the Food and Drug Administration Safety and Innovation Act. H.R. 2746, the Cancer Drug Coverage Parity Act. S. 752 , the Lung Cancer Mortality Reduction Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Medicare/Medicaid MMM
H.R. 905 / S. 733, to amend Part B of title XVIII of the Social Security Act. Meetings / education regarding physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.